U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515807) titled 'Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence' on March 31.
Brief Summary: Cardiovascular disease is the leading cause of death worldwide, and individuals with diabetes or other cardiometabolic conditions are at increased risk of adverse cardiovascular outcomes. Although advances in prevention and treatment have reduced cardiovascular events globally, cardiometabolic disease continues to represent a significant health burden, particularly in regions with high diabetes prevalence.In Qatar and other Gulf Cooperation Council countries, the prevalence of diabetes and obesity is increasing, contributin...